News - Oxymorphone
2012-05-01 02:30:58
Total quarterly revenues of $691 million, increased 23 percent versus prior year; Driven by full quarter addition of AMS as well as Qualitest revenue growth of 8 percent.
2012-03-22 02:25:26
CHADDS FORD, Pa., March 22, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP) announced today that it has acquired U.S.